Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes

NCT01720290 PHASE4 COMPLETED

This trial is conducted in Asia. The aim of this trial is to compare repaglinide and metformin administered alone or in combination in subjects with type 2 diabetes.

Details

Lead sponsor	Novo Nordisk A/S
Phase	PHASE4
Status	COMPLETED
Enrolment	150
Start date	Thu Jul 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Diabetes
• Diabetes Mellitus, Type 2

Interventions

• repaglinide
• metformin
• metformin

Countries

China